Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 10OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 2Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 83Urinary Bladder Neoplasms 31Carcinoma, Renal Cell 9Carcinoma, Transitional Cell 8Kidney Neoplasms 7Recurrence 5Prostatic Hyperplasia 5Neoplasms 5Disease 5Testicular Neoplasms 3Pain, Postoperative 3Pain 3Non-Muscle Invasive Bladder Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Anxiety Disorders 3Sleep Initiation and Maintenance Disorders 2Penile Neoplasms 2Pancreatic Neoplasms 2Motor Activity 2Melanoma 2Lymphoma 2Carcinoma, Hepatocellular 2Carcinoma 2Breast Neoplasms 2Adenocarcinoma 2Acute Kidney Injury 2Wilms Tumor 1Vulvar Neoplasms 1Vomiting 1Uterine Cervical Neoplasms 1

Interventions

Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Insulin Resistance × Genitourinary × Clear all
NCT01006395 2019-07-05

Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)

Austin Health

Phase 2/3 Completed
64 enrolled
Genitourinary

Insulin Resistance, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡